Regarding GLUT-1, previous studies have reported several associations between GLUT-1 expression, tumor aggressiveness, and poor prognosis in other malignant neoplasms, including colorectal cancer, pancreatic ductal adenocarcinoma, lung cancer, prostate cancer, and [42,43,44,45,46]. The gene discussed is SLC2A1; the disease is prostate cancer.